# Scribe Therapeutics, Inc. (SCTX)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/scribe-therapeutics-inc/ JSON: https://steadybase.io/company/scribe-therapeutics-inc.json Checked Nov 21, 2026. Latest filing read: Nov 12, 2026.

## Company

- Legal name: Scribe Therapeutics, Inc.
- Ticker: SCTX (Nasdaq)
- SEC CIK: 0001853921
- Industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
- Headquarters: Alameda, CA
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Website: scribetx.com
- Investor relations: https://investors.scribetx.com/
- LinkedIn: https://www.linkedin.com/company/scribe-therapeutics
- Next earnings date: Dec 2, 2026

## Key facts

- Shares outstanding: 18,937,519 as of Nov 6, 2026 (10-Q filed Nov 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1853921/000119312526458503/0001193125-26-458503-index.html

## Business

We’re unlocking the future of medicine with CRISPR-based therapeutics that are safe and effective enough to transform everyone's lifetime risk for disease.

Source: Company website description, https://www.scribetx.com/

## Officers and directors

- Benjamin L. Oakes, President, CEO. LinkedIn: https://linkedin.com/in/benjaminloakes. Source: Form 4 filed Jul 27, 2026, https://www.sec.gov/Archives/edgar/data/1853921/000212781426000004/0002127814-26-000004-index.htm
- David Parrot, Chief Financial Officer. LinkedIn: https://linkedin.com/in/davidlparrot. Source: Form 4 filed Jul 27, 2026, https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm
- Svetlana Lucas, Chief Business Officer. Source: Form 4 filed Jul 27, 2026, https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm

## Recent 8-K events

- Nov 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1853921/000119312526458486/sctx-20261112.htm
- Sep 2, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1853921/000119312526380184/sctx-20260902.htm
- Jul 27, 2026: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1853921/000119312526318263/d141508d8k.htm

## Insider trades (Form 4)

- Jul 28, 2026: Ventures LLC Avoro (Director) bought 2,391,238 shares, about $36.3M. Source: https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm
- Jul 28, 2026: Behzad Aghazadeh (Director) bought 2,391,238 shares, about $36.3M. Source: https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm
- Jul 28, 2026: Capital Advisors LLC Avoro (Director) bought 2,391,238 shares, about $36.3M. Source: https://www.sec.gov/Archives/edgar/data/1853921/000090266426003270/0000902664-26-003270-index.htm
- Jul 27, 2026: Carl L. Gordon (Director) bought 1,000,000 shares, about $15.0M. Source: https://www.sec.gov/Archives/edgar/data/1853921/000094787126000734/0000947871-26-000734-index.htm
- Jul 27, 2026: Capital GP VIII LLC OrbiMed (Director) bought 1,000,000 shares, about $15.0M. Source: https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm
- Jul 27, 2026: Advisors Llc Orbimed (Director) bought 1,000,000 shares, about $15.0M. Source: https://www.sec.gov/Archives/edgar/data/1853921/000094787126000733/0000947871-26-000733-index.htm
- Jul 23, 2026: David Parrot (Chief Financial Officer) bought 2,666 shares, about $39,990. Source: https://www.sec.gov/Archives/edgar/data/1853921/000212790826000004/0002127908-26-000004-index.htm
- Jul 23, 2026: Svetlana Lucas (Chief Business Officer) bought 3,000 shares, about $45,000. Source: https://www.sec.gov/Archives/edgar/data/1853921/000178129226000007/0001781292-26-000007-index.htm

## Latest filings

- 8-K filed Sep 2, 2026: https://www.sec.gov/Archives/edgar/data/1853921/000119312526380184/sctx-20260902.htm
- 10-Q filed Sep 2, 2026: https://www.sec.gov/Archives/edgar/data/1853921/000119312526380191/sctx-20260630.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/

